Results
|
|
9741.
|
|
|
|
9742.
|
|
|
|
9743.
|
|
|
|
9744.
|
|
|
|
9745.
|
|
|
|
9746.
|
|
|
|
9747.
|
|
|
|
9748.
|
|
|
|
9749.
|
|
|
|
9750.
|
|
|
|
9751.
|
|
|
|
9752.
|
|
|
|
9753.
|
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group. [electronic resource] by
- Le Cesne, A
- Judson, I
- Crowther, D
- Rodenhuis, S
- Keizer, H J
- Van Hoesel, Q
- Blay, J Y
- Frisch, J
- Van Glabbeke, M
- Hermans, C
- Van Oosterom, A
- Tursz, T
- Verweij, J
Producer: 20000801
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18
Availability: No items available.
|
|
|
9754.
|
|
|
|
9755.
|
|
|
|
9756.
|
|
|
|
9757.
|
|
|
|
9758.
|
|
|
|
9759.
|
|
|
|
9760.
|
|